MAU Test Device

The detection of microalbumin in urine serves as a supplementary diagnostic tool for identifying conditions such as diabetic nephropathy and other forms of renal impairment. The MAU (Microalbuminuria) Test Device is designed for the qualitative determination of albumin levels in urine through in vitro diagnostic testing. It is utilized as an auxiliary method in the diagnosis of chronic kidney injury (CKI), providing valuable insights into early renal dysfunction. By measuring albuminuria, this test aids healthcare professionals in monitoring kidney health and detecting potential damage at an early stage, enabling timely intervention and management.

1.Visual interpretation, convenient self-test;

2. The sample is urine, easy to obtain and non-invasive;

3. High accuracy;

4. Suitable for continuous monitoring of people with underlying diseases;

MAU (Microalbuminuria) is mainly used for early detection of kidney damage and cardiovascular disease risk assessment. Its detection significance includes: early kidney disease screening, cardiovascular disease risk assessment, management of metabolic syndrome and hypertension, etc.

So MAU trsting is important for for early disease intervention and chronic disease management, especially in the fields of diabetes, hypertension and cardiovascular disease.